1 documents found
Information × Registration Number 0103U008745, R & D request Title A randomised, double-blind, placebo controlled, multicentre, phase III study of Tarceva (erlotinib) plus chemotherapy (cisplatin and gemcitabine) versus chemotherapy alone in patients with advanced (stage IIIB or IV) non-small cell lung cancer (NSCLC) who have not received prior chemotherapy Head Пилипенко М.І, Registration Date 18-11-2003 Organization Grigoriev Institute for medical Radiology NAMS of Ukraine popup.description1 popup.nrat_date 2024-12-11 Close
search.res_rk
A randomised, double-blind, placebo controlled, multicentre, phase III study of Tarceva (erlotinib) plus chemotherapy (cisplatin and gemcitabine) versus chemotherapy alone in patients with advanced (stage IIIB or IV) non-small cell lung cancer (NSCLC) who have not received prior chemotherapy
Head: Пилипенко М.І. A randomised, double-blind, placebo controlled, multicentre, phase III study of Tarceva (erlotinib) plus chemotherapy (cisplatin and gemcitabine) versus chemotherapy alone in patients with advanced (stage IIIB or IV) non-small cell lung cancer (NSCLC) who have not received prior chemotherapy. Grigoriev Institute for medical Radiology NAMS of Ukraine. № 0103U008745
1 documents found

Updated: 2026-03-15


Роздрукувати цю сторінку